Nutriband Inc Warrant

Yahoo Finance • 4 days ago

Nutriband Inc. to Present at the MicroCap Rodeo Conference

ORLANDO, Fla., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (The Company) (Nasdaq:NTRB) (Nasdaq: NTRBW), announces it will participate in the MicroCap Rodeo Conference, to be held Thursday, June 25, 2025, in New York City. For exam... Full story

Yahoo Finance • 18 days ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

ORLANDO, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) reported its financial results for the six months ended July 31, 2025. The company reported a strong cash position at quarter end, reinforcing... Full story

Yahoo Finance • 25 days ago

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

ORLANDO, Fla., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of abuse deterrent pharmaceutical products announced today that it has seen warrants exercised at a strike... Full story

Yahoo Finance • 2 months ago

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

Sheridan will temporarily step aside as CEO to enter the Irish Presidential Election. Company Chairman and President, Serguei Melnik will take over as interim CEO over the course of the campaign and election period. ORLANDO, Fla., Aug.... Full story

Yahoo Finance • 2 months ago

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

FDA grants meeting for AVERSA™ FENTANYL (abuse deterrent transdermal system) to provide feedback on the Chemistry, Manufacturing, and Controls plans for the product through commercialization. Nutriband is partnering with Kindeva to develo... Full story

Yahoo Finance • 2 months ago

Nutriband announces key dates for 25% preferred stock dividend

ORLANDO - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a pharmaceutical company whose stock has surged nearly 89% over the past six months, has announced the schedule for its upcoming preferred stock dividend. The company, currently valued... Full story

Yahoo Finance • 2 months ago

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

ORLANDO, Fla., July 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) (“Nutriband” or the “Company”) is today reminding shareholders of the key dates associated with its upcoming 25% Preferred stock dividend. Shar... Full story

Yahoo Finance • 3 months ago

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

ORLANDO, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) (“Nutriband” or the “Company”) announced today that its Board of Directors has approved and declared a 25% preferred stock dividend. Shareholde... Full story

Yahoo Finance • 3 months ago

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), has been added as a member of the Russell Microcap, Russell Microcap Growth, Russell 3000E and Russell 3000E Growth Indexes, as part of the 202... Full story

Yahoo Finance • 3 months ago

Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030

PALM BEACH, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The market for abuse-deterrent opioids is still developing, but it’s estimated that replacing extended-release opioids with abuse-deterrent formulations... Full story

Yahoo Finance • 3 months ago

Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Nutriband and Kindeva have completed commercial manufacturing process scale-up for its lead product Aversa™ Fentanyl, an abuse-deterrent fentanyl patch Nutriband is partnering with Kindeva to develop Aversa™ Fentanyl which combines Nutrib... Full story

Yahoo Finance • 4 months ago

Nutriband issued U.S. patent for transdermal abuse deterrent technology

* Nutriband (NASDAQ:NTRB [https://seekingalpha.com/symbol/NTRB]) has announced that the U. S. Patent and Trademark Office issued patent number 12,318,492 on June 3, 2025, entitled "Abuse and Misuse Deterrent Transdermal Systems." * The... Full story

Yahoo Finance • 4 months ago

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

Patent issuance expands United States patent coverage for AVERSA™ transdermal abuse deterrent technology AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents iss... Full story

Yahoo Finance • 6 months ago

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

ORLANDO, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has received notification tha... Full story

Yahoo Finance • 6 months ago

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

ORLANDO, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it has signed an Associate Partnership agreement with C... Full story

Yahoo Finance • 6 months ago

Nutriband Signs Partnership Agreement with Charlotte FC

ORLANDO, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it has signed an Associate Partnership agreement with C... Full story

Yahoo Finance • 7 months ago

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received the Certificate of Registration from the United States Pa... Full story

Yahoo Finance • 7 months ago

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with Kindeva Drug Delivery to develop Aversa™... Full story

Yahoo Finance • 8 months ago

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

ORLANDO, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it received a Notice of Allowance... Full story

Yahoo Finance • 2 years ago

Nutriband With Kindeva Drug Delivery Select Aversa(TM) Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development

ORLANDO, FL / ACCESSWIRE / April 4, 2023 / Nutriband Inc.("Company") (NASDAQ:NTRB)(NASDAQ:NTRBW) with Kindeva Drug Delivery ("Kindeva") have selected the target AVERSA™ formulation to take forward into commercial scale manufacturing proces... Full story